The Republic of Korea excels in Thymoma treatment, with top institutions like Samsung Medical Center, Asan Medical Center, and Seoul National University Bundang Hospital (SNUBH) leading in advanced healthcare. Accredited by the Joint Commission International (JCI), these hospitals meet global standards. Samsung Medical Center's Comprehensive Cancer Center uses Novalis and Da Vinci systems for IGRT, robotic surgery, and targeted therapy. Asan Medical Center, South Korea's largest, achieves a 90% success rate in organ transplants and offers advanced Thymoma treatments.
SNUBH, a digital healthcare pioneer, uses the BESTcare system for precise Thymoma management, treating over 1,500,000 patients annually. Korea's Thymoma treatment success is notable, with improved survival rates due to immunotherapy, endoscopic thymectomy, proton beam therapy, and SBRT. For detailed statistics, see the figure with percents Thymoma.